President signs JOBS bill
This article was originally published in The Tan Sheet
Executive Summary
Multinational pharma, dietary supplement and nutritional product manufacturers will pay a reduced tax rate for repatriated foreign earnings after President Bush signed the legislation into law on Oct. 22. The bill cuts the repatriation tax rate from 35% to 5.25%, giving firms an incentive to repatriate earnings in the U.S. (1"The Tan Sheet" Oct. 18, 2004, p. 7). In an Oct. 29 earnings call, Schering-Plough CFO Bob Bertolini called the legislation "a very positive development" that will provide added financial flexibility, but noted it is "too early" to speculate how much of the firm's $9 bil. in undistributed foreign earnings will be repatriated...
You may also be interested in...
Pharma Firms Ready To Repatriate Billions Once “JOBS” Bill Is Signed
J&J intends to repatriate as much as $10 bil. held by foreign subsidiaries following President Bush's expected signing of the "JOBS" bill
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.